Nutraceuticals for Dissolving Nephrolites in Cats




Background: Nephrolithiasis is a condition frequently observed in felines, with or without concomitant chronic kidney disease, constituting the major cause of ureteral obstruction and causing progressive damage to the renal parenchyma. About 90% of nephrolites are composed of calcium oxalate, which cannot dissolve, and its incidence has increased substantially in recent years, along with its recurrence. There are functional foods known as nutraceuticals provides health benefits such as renoprotection. Due to these benefits and the high prevalence of nephrolithiasis in feline species, the present study aimed to evaluate the efficacy of the association of some nutraceuticals in the dissolution of nephrolites.

Materials, Methods & Results: The included cats had an ultrasound diagnosis of nephrolithiasis that, on clinical examination, showed: (i) the absence of previous or concomitant treatment for urinary infections and/or vesical and renal lithiasis; (ii) absence of genitourinary clinical manifestations; (iii) absence of obstructive processes; and (iv) absence of concomitant ureterolithiasis. We separated 51 cats with nephrolithiasis into 2 groups: control (n = 12) and study (n = 39). The control group received a placebo and the study group, nutraceuticals (magnesium chelate, resveratrol, vitamin K2, docosahexaenoic acid, and eicosapentaenoic acid). Laboratory tests (blood and urine) and abdominal imaging (ultrasound) were performed at day 0 and 30 days after enrollment. Monitoring the therapeutic efficacy in both groups was performed on day 30 for the CG and on days 30, 60, and 90 for the EG. The CG cats, after this step, were referred to surgery or to the EG, with prior authorization from their tutors. The diameter of nephrolites was significantly different before and after treatment, indicating a reduction in nephroliths over time. During the use of the nutraceutical formulation by the EG and use of placebo by the CG, there were no clinical and/or laboratory manifestations of side effects.

Discussion: The dissolution of nephrolites was correlated with the synergism promoted by the combination of nutraceuticals and not with the individual beneficial action of each nutraceutical since nutraceuticals have individually been used in isolation for a long time in veterinary medicine without having yielded the same benefit. Those undissolved were attributed to a different type of mineral composition than the one associated with the nutraceutical compound in this study, such as struvite or ammonium urate, of mixed composition or comprising solidified dried blood, which has shown an increasing increase in use in recent years. The dissolution of nephrolites was correlated with the synergism promoted by the combination of nutraceuticals and not with the individual beneficial action of each nutraceutical since nutraceuticals have individually been used in isolation for a long time in veterinary medicine without having yielded the same benefit. The undissolved nephrolites were attributed to the nephrolites that obtained partial dissolution at the end of 90 days, in that they possibly needed a longer time to obtain complete dissolution or that they present another mineral composition in their nucleus; that is, it is a compound-type urolith. The nutraceutical compound proved to be effective in the dissolution of nephrolites in the cats included in this study, and the time of use (up to 90 days) showed no negative influence on the clinical or laboratory tests during the entire treatment period.

Keywords: cats, food supplement, functional foods, natural products, nephrolithiasis, nutraceuticals.


Download data is not yet available.


Alford A., Borofsky M., Minneapolis M.N., Furrow E., Lulich J. & St. Paul M.N. 2020. Naturally-occurring calcium oxalate stones in animals: a quantitative review of submissions to the minnesota urolith center from 2011 to 2018. Journal of Urology. 203(4): 1-7.

Bartges J. 2011. Urinary Saturation and Urolithiasis. In: Bartges J. (Ed). Uma Actualização Científica Para Uma Abordagem Segura, Eficaz e Simples da Urolítiase Felina. Lisboa: Nestlé Purina, pp.1-13.

Bartges J.W. 2016. Feline Calcium Oxalate Urolithiasis: Risk factors and rational treatment approaches. Journal of Feline Medicine and Surgery. 18(9): 712-722. doi: 10.1177/1098612X16660442.

Bartges J. & Callens A.J. 2016. Urolithiasis. Veterinary Clinics of North America - Small Animals Practice. 45(4): 747-768.

Bartges J.W., Kirk C.A., Cox S.K. & Moyers T.D. 2013. Influence of acidifying or alkalinizing diets on bone mineral density and urine relative supersaturation with calcium oxalate and struvite in healthy cats. American Journal of Veterinary Research. 74(10): 1347-1352. doi:10.2460/ajvr.74.10.1347.

Berent A. 2014. Diagnosis and Management of Feline Ureteral Obstructions: Past, Present and Future. ACVIM Forum 2014. Denver: ACVIM, pp.1-10.

Brower V. 1998. Nutraceuticals: poised for a healthy slice of the healthcare market? Nature biotechnology.16(8): 728-731. doi: 10.1038/nbt0898-728.

Brown L., Caligiuri S.P.B., Brown D. & Pierce G.N. 2018. Clinical trials using functional foods provide unique challenges. Journal of Functional Foods. 45(1): 233-238. doi: 10.1016/j.jff.2018.01.024.

Cannon A.B., Westropp J.L., Ruby A.L. & Kass P.H. 2007. Evaluation of trends in urolith composition in cats: 5,230 cases (1985-2004). Journal of the American Veterinary Medical Association. 231(4): 570-576. doi: 10.2460/javma.231.4.570.

Chacar F.C., Kogika M.M., Ferreira C.A., Kanayama K.K. & Reche A. 2019. Total serum magnesium in cats with chronic kidney disease with nephrolithiasis. Journal of Feline Medicine and Surgery. 21(12): 1172-1180. doi: 10.1177/1098612X18823588.

Cunha A.R., D'El-Rei J., Medeiros F., Umbelino B., Oigman W., Touyz R.M. & Neves M.F. 2017. Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women. Journal of Hypertension. 35(1): 89-97. doi:10.1097/hjh.00000000000 01129.

Debruyn K., Haers H., Combes A., Paepa D., Kathelijne P. & Vanderperren K. 2012. Ultrasonography of the feline kidney: technique, anatomy and changes associated with disease. Journal of Feline Medicine and Surgery. 14(11): 794-803. doi: 10.1177/1098612X12464461.

Dibartola S.P. & Westropp J.L. 2015. Urolitíase Canina e Felina. In: Nelson R.W. & Couto C.G. (Eds). Medicina Interna de Pequenos Animais. 5.ed. Rio de Janeiro: Elsevier, pp.687-697.

França J., Saad F.M.O.B., Saad C.E.P., Silva R.C. & Reis J.S. 2011. Avaliação de ingredientes convencionais e alternativos em rações de cães e gatos. Revista Brasileira de Zootecnia. 40(1): 222-231.

Jain N.C. 1993. Renal biochemistry. In: Jain N.C. (Ed). Essentials of Veterinary Hematology. Philadelphia: Wiley, pp.245-287.

Kyles A.E., Hardie E.M., Wooden B.G., Adin C.A., Stone E.A., Gregory C.R., Mathews K.G., Cowgill L.D., Vaden S., Nyland T.G. & Ling G.V. 2005. Clinical, clinicopathologic, radiographic, and ultrasonographic abnormalities in cats with ureteral calculi: 163 cases (1984-2002). Journal of the American Veterinary Medical Association. 226(6): 932-936. doi:10.2460/javma.2005.226.932.

Lulich J.P., Osborne C.A. & Bartges J.W. 2004. Distúrbios do trato urinário inferior dos caninos. In: Ettinger S.J. & Feldman E.C. (Eds). Tratado de Medicina Interna Veterinária. 5.ed. Rio de Janeiro: Guanabara Koogan, pp.1841-1877.

Musso C.G. 2009. Magnesium metabolism in health and disease. International Urology and Nephrology. 41(2): 357-362. doi:10.1007/s11255-009-9548-7.

Nyland T.G., Widmer W.R. & Matton J.S. 2015. Urinary tract. In: Mattoon J.S. & Nyland T.G. (Eds). Small Animal Diagnostic Ultrasound. 3rd edn. St. Louis: Elsevier, pp.557-607.

Pan M.H., Wu J.C., Ho C.T. & Lai C.S. 2018. Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene. Biofactors. 44(1): 50-60. doi: 10.1002/biof.1409.

Pimenta M.M., Reche-Júnior A., Freitas M.F., Kogika M.M. & Hagiwara M.K. 2014. Estudo da ocorrência de litíase renal e ureteral em gatos com doença renal crônica. Pesquisa Veterinária Brasileira. 34(6): 555-561.

Polzin D.J. 2017. Chronic Kidney Disease. In: Ettinger S.J., Feldman E.C. & Côté E. (Eds). Textbook of Veterinary Internal Medicine. 8th edn. St. Louis: Saunders Elsevier, pp.4693-4734.



How to Cite

Freitas, R. de A., Alberigi, B. S., Bendas, A. J. R., da Veiga, C. C. P., Filho, M. dos S., Corrêa, L. M., & Carvalho, V. de A. N. (2022). Nutraceuticals for Dissolving Nephrolites in Cats. Acta Scientiae Veterinariae, 50.




Most read articles by the same author(s)